Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Weizmann Institute of Science
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: March 10, 2011
Last updated: April 5, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: April 2013
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)